Eisai EMEA News and Activities

Eisai EMEA is owned by Eisai.

Eisai is one of the...

• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Eisai is a company listed under the stock ticker 4523 (JP).

Eisai has a direct presence in 11 countries.

Eisai has 12 subsidiaries including EA Pharma, Eisai Americas and Eisai Australia.

They are in:

• Pharmaceuticals92%
• Biotechnology8%

View the org chart displaying its 22 main executives

Most searched biographies at Eisai EMEA

• Nick Burgin, President and Chief Operating Officer, President Glob...
• Miguel Marcao, Vice President Oncology
• Laura Barbetti, Chief Financial Officer

Popular executive movements at Eisai

• Akiko Nakahama who was Vice President, Chief Portfolio Officer, Asia Filing and Registration, Chief Quality Officer and Japan Regulatory Affairs, becomes Vice President Manufacturing, Quality and Technology,  (posted on April 28 2026).
• Terushige Iike who was Executive Vice President, Chief Strategy and Planning Officer, becomes Executive Vice President Chief Business Officer, Internal Audit  (posted on April 28 2026).

Create your alert
to follow the executive moves at Eisai EMEA.

Eisai has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Eisai EMEA

Social media about Eisai EMEA

• Eisai EMEA on Wikipedia, Google News & Yahoo Finance
• Eisai EMEA on LinkedIn, X (Twitter) & YouTube